查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1839255

免疫腫瘤藥物市場分析及預測（至2034年）：類型、產品、技術、應用、最終用戶、階段、功能、部署、解決方案和模式

Immuno Oncology Drugs Market Analysis and Forecast to 2034: Type, Product, Technology, Application, End User, Stage, Functionality, Deployment, Solutions, Mode
出版日期: | 出版商: Global Insight Services | 英文 352 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計免疫腫瘤學市場規模將從2024年的1,259億美元增加至2034年的6,341億美元，複合年成長率約為17.5%。免疫腫瘤學市場涵蓋利用人體免疫系統對抗癌症的療法，例如查核點抑制劑、單株抗體和疫苗。生物技術的進步和癌症發病率的上升推動了該市場的發展。關鍵趨勢包括個人化醫療和聯合治療，這些療法有望提高療效並減少副作用。持續的研究和臨床試驗至關重要，它們能夠刺激創新並拓展治療方案，從而推動市場成長。

受癌症治療技術進步和患者認知度提升的推動，免疫腫瘤市場正經歷強勁成長。單株抗體憑藉其靶向癌細胞的特異性和有效性，成為其細分市場中表現最佳的藥物之一。查核點抑制劑能夠增強免疫系統的抗癌能力，其臨床結果也令人鼓舞。過繼性細胞轉移療法，尤其是嵌合抗原受體T細胞療法，透過提供個人化治療方案，正成為市場的重要貢獻者。細胞細胞激素療法和溶細胞病毒療法也發展勢頭強勁，體現了該領域的持續技術創新。整合多種免疫腫瘤療法的聯合治療日益受到青睞，能夠提高療效和患者預後。新型生物標記和診斷工具的持續開發，使得更精準、更有效的治療策略成為可能，從而支撐了市場的成長軌跡。製藥公司之間的策略聯盟和夥伴關係正在進一步加速市場擴張。

市場區隔
類型 單株抗體、癌症疫苗、查核點抑制劑、細胞激素、CAR-T細胞療法、癌細胞溶解病毒療法、細胞移植、雙特異性抗體、抗體藥物複合體
產品 治療、預防、輔助及診斷藥物
科技 基因體學、蛋白質體學、生物資訊學、奈米技術、生物技術
目的 肺癌、乳癌、結腸癌、攝護腺癌、黑色素瘤、血癌、消化系統癌症、婦科癌症
最終用戶 醫院、癌症研究中心、專科診所、製藥公司、生技公司、學術和研究機構
步 研發、臨床試驗和商業化
功能 免疫活化、免疫抑制、免疫調節
部署 本地、雲端基礎、混合
解決方案 治療、診斷和監測
模式 靜脈、口服、皮下、肌肉注射

市場概述

免疫腫瘤市場充滿活力，市佔率波動劇烈。定價策略至關重要，因為各公司都在努力平衡價格承受能力和技術創新。新產品的推出正在推動市場發展，尤其是利用免疫系統對抗癌症的新型療法。這些進步正在重塑治療方法，刺激競爭加劇，並創造充滿活力的市場環境。競爭基準基準化分析表明，主要企業正在不斷完善其策略，以鞏固其市場地位。監管影響力至關重要，尤其是在北美和歐洲，因為它們制定了影響市場准入和產品開發的嚴格標準。競爭格局的特點是策略聯盟、併購，這些對於維持競爭優勢至關重要。在技​​術進步和研發投入不斷增加的推動下，市場可望實現成長。挑戰包括克服複雜的監管途徑和管理高昂的開發成本，但創新潛力仍然巨大。

主要趨勢和促進因素

受癌症免疫療法的進步和癌症發病率上升的推動，免疫腫瘤藥物市場正經歷強勁成長。主要趨勢包括個人化治療和聯合治療的發展、療效的提高和患者預後的改善。人們對查核點抑制劑和 CAR-T 細胞療法的日益關注正在重塑治療格局，並為創新提供有希望的途徑。製藥公司正大力投資研發新型免疫調節劑。監管支持和加快核准流程正在加速新治療方法的市場准入。不斷擴大的免疫腫瘤藥物管線代表著一個充滿活力的競爭環境。生物技術公司和學術機構之間的合作正在刺激前沿研究，進一步推動市場成長。此外，人工智慧在藥物發現中的整合正在簡化開發流程並縮短上市時間。新興市場提供了豐富的商機，不斷改善的醫療基礎設施和日益成長的免疫腫瘤治療意識正在推動需求。隨著精準醫療日益成為主流，市場可望繼續擴張。

限制與挑戰：

免疫腫瘤藥物市場目前面臨幾個重大的市場限制和挑戰。一個關鍵的挑戰是與開發和生產這些藥物相關的高成本。這種經濟負擔限制了患者獲得藥物的可近性和可負擔性，抑制了市場成長。此外，嚴格的監管要求和冗長的核准流程可能會延遲新治療方法的推出並對市場動態產生負面影響。臨床試驗設計的複雜性也是一個迫切的問題，通常需要大量的患者和很長時間才能證明療效。這種複雜性會阻礙及時進入市場。此外，不同癌症類型的異質性需要個人化的治療方法，使治療標準化變得複雜。最後，實現廣泛採用仍然是一個挑戰，因為來自成熟癌症療法的競爭，熟悉其療效和安全性的醫療服務提供者可能更喜歡這些療法。

主要企業

Adaptimmune Therapeutics、Agenus、Immunocore、MacroGenics、OncoSec Medical、Surface Oncology、Celyad Oncology、Kura Oncology、Iovance Biotherapeutics、TCR2 Therapeutics、Calithera Biosciences、Harpoon Therapeutics、Gritstone.

目錄

第 1 章 免疫腫瘤學市場概述

  • 調查目的
  • 免疫腫瘤藥物市場定義與研究範圍
  • 報告限制
  • 調查年份和貨幣
  • 調查方法

第2章執行摘要

第3章：重要考察

第4章 免疫腫瘤藥物市場展望

  • 免疫腫瘤藥物市場細分
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 價值鏈分析
  • 4P模型
  • 安索夫矩陣

第5章：免疫腫瘤藥物的市場策略

  • 母市場分析
  • 供需分析
  • 消費者購買意向
  • 案例研究分析
  • 定價分析
  • 監管狀況
  • 供應鏈分析
  • 競爭產品分析
  • 近期動態

第6章免疫腫瘤藥物市場規模

  • 免疫腫瘤藥物市場規模（以價值計算）
  • 免疫腫瘤藥物市場規模（按數量計算）

第 7 章：免疫腫瘤藥物市場規模（按類型）

  • 市場概況
  • 單株抗體
  • 癌症疫苗
  • 查核點抑制劑
  • 細胞激素
  • CAR-T細胞療法
  • 溶瘤病毒療法
  • 過繼細胞移植
  • 雙特異性抗體
  • 抗體藥物複合體
  • 其他

第 8 章：免疫腫瘤藥物市場（按產品）

  • 市場概況
  • 治療藥物
  • 預防性藥物
  • 輔助用藥
  • 診斷劑
  • 其他

第9章 免疫腫瘤藥物市場（依技術）

  • 市場概況
  • 基因組學
  • 蛋白質體學
  • 生物資訊學
  • 奈米科技
  • 生物技術
  • 其他

第 10 章免疫腫瘤藥物市場（按應用）

  • 市場概況
  • 肺癌
  • 乳癌
  • 大腸直腸癌
  • 攝護腺癌
  • 黑色素瘤
  • 血癌
  • 消化系統癌症
  • 婦科癌症
  • 其他

第 11 章免疫腫瘤藥物市場（按最終用戶）

  • 市場概況
  • 醫院
  • 癌症研究中心
  • 專科診所
  • 製藥公司
  • 生技公司
  • 學術研究機構
  • 其他

第 12 章：免疫腫瘤藥物市場（按階段）

  • 市場概況
  • 研究與開發
  • 臨床試驗
  • 商業化
  • 其他

第 13 章免疫腫瘤藥物市場（依功能）

  • 市場概況
  • 免疫活化
  • 免疫抑制
  • 免疫調節
  • 其他

第 14 章免疫腫瘤藥物市場（按部署）

  • 市場概況
  • 本地部署
  • 雲端基礎
  • 混合
  • 其他

第 15 章免疫腫瘤藥物市場（依解決方案）

  • 市場概況
  • 治療藥物
  • 診斷劑
  • 監控
  • 其他

第 16 章免疫腫瘤藥物市場（按模式）

  • 市場概況
  • 靜脈注射
  • 口服
  • 皮下注射
  • 肌肉注射
  • 其他

第 17 章免疫腫瘤藥物市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 瑞典
    • 瑞士
    • 丹麥
    • 芬蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 新加坡
    • 印尼
    • 台灣
    • 馬來西亞
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區

第18章競爭格局

  • 概述
  • 市佔率分析
  • 主要企業定位
  • 衝突領導地圖
  • 供應商基準化分析
  • 發展策略基準化分析

第19章：公司簡介

  • Adaptimmune Therapeutics
  • Agenus
  • Immunocore
  • MacroGenics
  • OncoSec Medical
  • Surface Oncology
  • Celyad Oncology
  • Kura Oncology
  • Iovance Biotherapeutics
  • TCR2 Therapeutics
  • Calithera Biosciences
  • Harpoon Therapeutics
  • Gritstone bio
  • NextCure
  • ImmunoGen
簡介目錄
Product Code: GIS33961

Immuno Oncology Drugs Market is anticipated to expand from $125.9 billion in 2024 to $634.1 billion by 2034, growing at a CAGR of approximately 17.5%. The Immuno Oncology Drugs Market encompasses therapeutics that harness the body's immune system to combat cancer, including checkpoint inhibitors, monoclonal antibodies, and vaccines. This market is driven by advancements in biotechnology and rising cancer prevalence. Key trends include personalized medicine and combination therapies, promising enhanced efficacy and reduced side effects. Ongoing research and clinical trials are pivotal, fostering innovation and expanding treatment options, thereby propelling market growth.

The Immuno Oncology Drugs Market is experiencing robust growth, propelled by advancements in cancer treatment methodologies and increasing patient awareness. The monoclonal antibodies segment stands out as the top-performing sub-segment, driven by their specificity and efficacy in targeting cancer cells. Checkpoint inhibitors, which enhance the immune system's ability to fight cancer, are the second highest-performing sub-segment, gaining traction due to promising clinical outcomes. Adoptive cell transfer therapies, particularly CAR-T cell therapy, are emerging as significant contributors to the market, offering personalized treatment options. Cytokines and oncolytic virus therapies are also gaining momentum, reflecting ongoing innovation in the field. Combination therapies, integrating multiple immuno-oncology approaches, are increasingly preferred, enhancing treatment efficacy and patient outcomes. The continuous development of novel biomarkers and diagnostic tools supports the growth trajectory, enabling more precise and effective treatment strategies. Strategic collaborations and partnerships among pharmaceutical companies further accelerate market expansion.

Market Segmentation
TypeMonoclonal Antibodies, Cancer Vaccines, Checkpoint Inhibitors, Cytokines, CAR-T Cell Therapy, Oncolytic Virus Therapy, Adoptive Cell Transfer, Bispecific Antibodies, Antibody-Drug Conjugates
ProductTherapeutic Drugs, Preventive Drugs, Adjunctive Drugs, Diagnostic Agents
TechnologyGenomics, Proteomics, Bioinformatics, Nanotechnology, Biotechnology
ApplicationLung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Blood Cancers, Gastrointestinal Cancers, Gynecological Cancers
End UserHospitals, Cancer Research Centers, Specialty Clinics, Pharmaceutical Companies, Biotechnology Companies, Academic and Research Institutes
StageResearch and Development, Clinical Trials, Commercialized
FunctionalityImmune Activation, Immune Suppression, Immune Modulation
DeploymentOn-Premise, Cloud-Based, Hybrid
SolutionsTherapeutics, Diagnostics, Monitoring
ModeIntravenous, Oral, Subcutaneous, Intramuscular

Market Snapshot:

The Immuno Oncology Drugs Market is witnessing a dynamic landscape with significant shifts in market share. Pricing strategies have become pivotal, as companies strive to balance affordability with innovation. New product launches are invigorating the market, with a particular focus on novel therapies that harness the immune system to combat cancer. These advancements are reshaping therapeutic approaches, driving increased competition and fostering a vibrant market environment. In terms of competition benchmarking, key players are continuously strategizing to enhance their market position. Regulatory influences, particularly in North America and Europe, are crucial, as they set stringent standards that impact market entry and product development. The competitive landscape is characterized by strategic alliances, mergers, and acquisitions, which are pivotal in maintaining a competitive edge. The market is poised for growth, driven by technological advancements and increased R&D investments. Challenges include navigating complex regulatory pathways and managing high development costs, yet the potential for innovation remains substantial.

Geographical Overview:

The Immuno Oncology Drugs Market is witnessing robust growth across various regions, each demonstrating unique opportunities. North America leads the market, driven by substantial investments in cancer research and a strong focus on advanced therapies. The presence of key pharmaceutical companies and a favorable regulatory environment further bolster the region's growth. Europe follows, with a significant emphasis on research and development, supported by governmental initiatives and collaborations. The region's commitment to healthcare innovation enhances its market potential. In the Asia Pacific, rapid economic development and increasing healthcare expenditure are propelling market expansion. Countries like China and India are emerging as key players, driven by large patient populations and growing awareness of immuno-oncology therapies. Latin America and the Middle East & Africa present promising growth pockets. In Latin America, improving healthcare infrastructure and increasing cancer prevalence are driving demand. Meanwhile, the Middle East & Africa are recognizing the importance of advanced cancer treatments, with investments in healthcare facilities and research initiatives.

Key Trends and Drivers:

The Immuno Oncology Drugs Market is experiencing robust growth driven by advancements in cancer immunotherapy and rising cancer prevalence. Key trends include the development of personalized therapies and combination treatments, enhancing efficacy and patient outcomes. The increasing focus on checkpoint inhibitors and CAR-T cell therapies is reshaping the treatment landscape, offering promising avenues for innovation. Pharmaceutical companies are heavily investing in research and development to discover novel immune-modulating agents. Regulatory support and expedited approval processes are accelerating the market entry of new therapies. The expanding pipeline of immuno-oncology drugs signifies a dynamic and competitive environment. Collaborations between biotech firms and academic institutions are fostering cutting-edge research, further propelling market growth. Moreover, the integration of artificial intelligence in drug discovery is streamlining development processes, reducing time to market. Opportunities abound in emerging markets, where healthcare infrastructure improvements and rising awareness of immuno-oncology therapies are driving demand. The market is poised for continuous expansion as precision medicine becomes increasingly mainstream.

Restraints and Challenges:

The Immuno Oncology Drugs Market is currently confronted with several significant restraints and challenges. A primary challenge is the high cost associated with the development and production of these drugs. This financial burden can limit accessibility and affordability for patients, thereby restricting market growth. Additionally, stringent regulatory requirements and prolonged approval processes can delay the introduction of new therapies, impacting market dynamics adversely. Another pressing issue is the complexity of clinical trial designs, which often require large patient populations and extended periods to demonstrate efficacy. This complexity can impede timely market entry. Furthermore, the heterogeneity of cancer types presents a challenge, as it necessitates personalized treatment approaches, complicating the standardization of therapies. Lastly, there is an ongoing challenge in achieving widespread adoption due to existing competition from established cancer treatments, which may be preferred by healthcare providers familiar with their efficacy and safety profiles.

Key Players:

Adaptimmune Therapeutics, Agenus, Immunocore, MacroGenics, OncoSec Medical, Surface Oncology, Celyad Oncology, Kura Oncology, Iovance Biotherapeutics, TCR2 Therapeutics, Calithera Biosciences, Harpoon Therapeutics, Gritstone bio, NextCure, ImmunoGen

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Immuno Oncology Drugs Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Immuno Oncology Drugs Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Technology
  • 2.6 Key Highlights of the Market, by Application
  • 2.7 Key Highlights of the Market, by End User
  • 2.8 Key Highlights of the Market, by Stage
  • 2.9 Key Highlights of the Market, by Functionality
  • 2.10 Key Highlights of the Market, by Deployment
  • 2.11 Key Highlights of the Market, by Solutions
  • 2.12 Key Highlights of the Market, by Mode
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Technology
  • 3.5 Market Attractiveness Analysis, by Application
  • 3.6 Market Attractiveness Analysis, by End User
  • 3.7 Market Attractiveness Analysis, by Stage
  • 3.8 Market Attractiveness Analysis, by Functionality
  • 3.9 Market Attractiveness Analysis, by Deployment
  • 3.10 Market Attractiveness Analysis, by Solutions
  • 3.11 Market Attractiveness Analysis, by Mode
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Immuno Oncology Drugs Market Outlook

  • 4.1 Immuno Oncology Drugs Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Immuno Oncology Drugs Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Immuno Oncology Drugs Market Size

  • 6.1 Immuno Oncology Drugs Market Size, by Value
  • 6.2 Immuno Oncology Drugs Market Size, by Volume

7: Immuno Oncology Drugs Market, by Type

  • 7.1 Market Overview
  • 7.2 Monoclonal Antibodies
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Cancer Vaccines
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Checkpoint Inhibitors
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Cytokines
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 CAR-T Cell Therapy
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Oncolytic Virus Therapy
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 Adoptive Cell Transfer
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region
  • 7.9 Bispecific Antibodies
    • 7.9.1 Key Market Trends & Opportunity Analysis
    • 7.9.2 Market Size and Forecast, by Region
  • 7.10 Antibody-Drug Conjugates
    • 7.10.1 Key Market Trends & Opportunity Analysis
    • 7.10.2 Market Size and Forecast, by Region
  • 7.11 Others
    • 7.11.1 Key Market Trends & Opportunity Analysis
    • 7.11.2 Market Size and Forecast, by Region

8: Immuno Oncology Drugs Market, by Product

  • 8.1 Market Overview
  • 8.2 Therapeutic Drugs
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Preventive Drugs
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Adjunctive Drugs
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Diagnostic Agents
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: Immuno Oncology Drugs Market, by Technology

  • 9.1 Market Overview
  • 9.2 Genomics
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Proteomics
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Bioinformatics
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Nanotechnology
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Biotechnology
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Others
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region

10: Immuno Oncology Drugs Market, by Application

  • 10.1 Market Overview
  • 10.2 Lung Cancer
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Breast Cancer
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Colorectal Cancer
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Prostate Cancer
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Melanoma
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Blood Cancers
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region
  • 10.8 Gastrointestinal Cancers
    • 10.8.1 Key Market Trends & Opportunity Analysis
    • 10.8.2 Market Size and Forecast, by Region
  • 10.9 Gynecological Cancers
    • 10.9.1 Key Market Trends & Opportunity Analysis
    • 10.9.2 Market Size and Forecast, by Region
  • 10.10 Others
    • 10.10.1 Key Market Trends & Opportunity Analysis
    • 10.10.2 Market Size and Forecast, by Region

11: Immuno Oncology Drugs Market, by End User

  • 11.1 Market Overview
  • 11.2 Hospitals
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Cancer Research Centers
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Specialty Clinics
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Pharmaceutical Companies
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Biotechnology Companies
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Academic and Research Institutes
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region
  • 11.8 Others
    • 11.8.1 Key Market Trends & Opportunity Analysis
    • 11.8.2 Market Size and Forecast, by Region

12: Immuno Oncology Drugs Market, by Stage

  • 12.1 Market Overview
  • 12.2 Research and Development
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Clinical Trials
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Commercialized
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Others
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region

13: Immuno Oncology Drugs Market, by Functionality

  • 13.1 Market Overview
  • 13.2 Immune Activation
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Immune Suppression
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Immune Modulation
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Others
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region

14: Immuno Oncology Drugs Market, by Deployment

  • 14.1 Market Overview
  • 14.2 On-Premise
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Cloud-Based
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Hybrid
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: Immuno Oncology Drugs Market, by Solutions

  • 15.1 Market Overview
  • 15.2 Therapeutics
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Diagnostics
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Monitoring
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Immuno Oncology Drugs Market, by Mode

  • 16.1 Market Overview
  • 16.2 Intravenous
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Oral
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Subcutaneous
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region
  • 16.5 Intramuscular
    • 16.5.1 Key Market Trends & Opportunity Analysis
    • 16.5.2 Market Size and Forecast, by Region
  • 16.6 Others
    • 16.6.1 Key Market Trends & Opportunity Analysis
    • 16.6.2 Market Size and Forecast, by Region

17: Immuno Oncology Drugs Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Technology
    • 17.2.5 North America Market Size and Forecast, by Application
    • 17.2.6 North America Market Size and Forecast, by End User
    • 17.2.7 North America Market Size and Forecast, by Stage
    • 17.2.8 North America Market Size and Forecast, by Functionality
    • 17.2.9 North America Market Size and Forecast, by Deployment
    • 17.2.10 North America Market Size and Forecast, by Solutions
    • 17.2.11 North America Market Size and Forecast, by Mode
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Technology
      • 17.2.9.4 United States Market Size and Forecast, by Application
      • 17.2.9.5 United States Market Size and Forecast, by End User
      • 17.2.9.6 United States Market Size and Forecast, by Stage
      • 17.2.9.7 United States Market Size and Forecast, by Functionality
      • 17.2.9.8 United States Market Size and Forecast, by Deployment
      • 17.2.9.9 United States Market Size and Forecast, by Solutions
      • 17.2.9.10 United States Market Size and Forecast, by Mode
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Technology
      • 17.2.10.4 Canada Market Size and Forecast, by Application
      • 17.2.10.5 Canada Market Size and Forecast, by End User
      • 17.2.10.6 Canada Market Size and Forecast, by Stage
      • 17.2.10.7 Canada Market Size and Forecast, by Functionality
      • 17.2.10.8 Canada Market Size and Forecast, by Deployment
      • 17.2.10.9 Canada Market Size and Forecast, by Solutions
      • 17.2.10.10 Canada Market Size and Forecast, by Mode
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Technology
    • 17.3.5 Europe Market Size and Forecast, by Application
    • 17.3.6 Europe Market Size and Forecast, by End User
    • 17.3.7 Europe Market Size and Forecast, by Stage
    • 17.3.8 Europe Market Size and Forecast, by Functionality
    • 17.3.9 Europe Market Size and Forecast, by Deployment
    • 17.3.10 Europe Market Size and Forecast, by Solutions
    • 17.3.11 Europe Market Size and Forecast, by Mode
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.5 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.6 United Kingdom Market Size and Forecast, by Stage
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Functionality
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Deployment
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Solutions
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Mode
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Technology
      • 17.3.10.4 Germany Market Size and Forecast, by Application
      • 17.3.10.5 Germany Market Size and Forecast, by End User
      • 17.3.10.6 Germany Market Size and Forecast, by Stage
      • 17.3.10.7 Germany Market Size and Forecast, by Functionality
      • 17.3.10.8 Germany Market Size and Forecast, by Deployment
      • 17.3.10.9 Germany Market Size and Forecast, by Solutions
      • 17.3.10.10 Germany Market Size and Forecast, by Mode
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Technology
      • 17.3.11.4 France Market Size and Forecast, by Application
      • 17.3.11.5 France Market Size and Forecast, by End User
      • 17.3.11.6 France Market Size and Forecast, by Stage
      • 17.3.11.7 France Market Size and Forecast, by Functionality
      • 17.3.11.8 France Market Size and Forecast, by Deployment
      • 17.3.11.9 France Market Size and Forecast, by Solutions
      • 17.3.11.10 France Market Size and Forecast, by Mode
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Technology
      • 17.3.12.4 Spain Market Size and Forecast, by Application
      • 17.3.12.5 Spain Market Size and Forecast, by End User
      • 17.3.12.6 Spain Market Size and Forecast, by Stage
      • 17.3.12.7 Spain Market Size and Forecast, by Functionality
      • 17.3.12.8 Spain Market Size and Forecast, by Deployment
      • 17.3.12.9 Spain Market Size and Forecast, by Solutions
      • 17.3.12.10 Spain Market Size and Forecast, by Mode
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Technology
      • 17.3.13.4 Italy Market Size and Forecast, by Application
      • 17.3.13.5 Italy Market Size and Forecast, by End User
      • 17.3.13.6 Italy Market Size and Forecast, by Stage
      • 17.3.13.7 Italy Market Size and Forecast, by Functionality
      • 17.3.13.8 Italy Market Size and Forecast, by Deployment
      • 17.3.13.9 Italy Market Size and Forecast, by Solutions
      • 17.3.13.10 Italy Market Size and Forecast, by Mode
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.4 Netherlands Market Size and Forecast, by Application
      • 17.3.14.5 Netherlands Market Size and Forecast, by End User
      • 17.3.14.6 Netherlands Market Size and Forecast, by Stage
      • 17.3.14.7 Netherlands Market Size and Forecast, by Functionality
      • 17.3.14.8 Netherlands Market Size and Forecast, by Deployment
      • 17.3.14.9 Netherlands Market Size and Forecast, by Solutions
      • 17.3.14.10 Netherlands Market Size and Forecast, by Mode
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Technology
      • 17.3.15.4 Sweden Market Size and Forecast, by Application
      • 17.3.15.5 Sweden Market Size and Forecast, by End User
      • 17.3.15.6 Sweden Market Size and Forecast, by Stage
      • 17.3.15.7 Sweden Market Size and Forecast, by Functionality
      • 17.3.15.8 Sweden Market Size and Forecast, by Deployment
      • 17.3.15.9 Sweden Market Size and Forecast, by Solutions
      • 17.3.15.10 Sweden Market Size and Forecast, by Mode
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.4 Switzerland Market Size and Forecast, by Application
      • 17.3.16.5 Switzerland Market Size and Forecast, by End User
      • 17.3.16.6 Switzerland Market Size and Forecast, by Stage
      • 17.3.16.7 Switzerland Market Size and Forecast, by Functionality
      • 17.3.16.8 Switzerland Market Size and Forecast, by Deployment
      • 17.3.16.9 Switzerland Market Size and Forecast, by Solutions
      • 17.3.16.10 Switzerland Market Size and Forecast, by Mode
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Technology
      • 17.3.17.4 Denmark Market Size and Forecast, by Application
      • 17.3.17.5 Denmark Market Size and Forecast, by End User
      • 17.3.17.6 Denmark Market Size and Forecast, by Stage
      • 17.3.17.7 Denmark Market Size and Forecast, by Functionality
      • 17.3.17.8 Denmark Market Size and Forecast, by Deployment
      • 17.3.17.9 Denmark Market Size and Forecast, by Solutions
      • 17.3.17.10 Denmark Market Size and Forecast, by Mode
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Technology
      • 17.3.18.4 Finland Market Size and Forecast, by Application
      • 17.3.18.5 Finland Market Size and Forecast, by End User
      • 17.3.18.6 Finland Market Size and Forecast, by Stage
      • 17.3.18.7 Finland Market Size and Forecast, by Functionality
      • 17.3.18.8 Finland Market Size and Forecast, by Deployment
      • 17.3.18.9 Finland Market Size and Forecast, by Solutions
      • 17.3.18.10 Finland Market Size and Forecast, by Mode
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Technology
      • 17.3.19.4 Russia Market Size and Forecast, by Application
      • 17.3.19.5 Russia Market Size and Forecast, by End User
      • 17.3.19.6 Russia Market Size and Forecast, by Stage
      • 17.3.19.7 Russia Market Size and Forecast, by Functionality
      • 17.3.19.8 Russia Market Size and Forecast, by Deployment
      • 17.3.19.9 Russia Market Size and Forecast, by Solutions
      • 17.3.19.10 Russia Market Size and Forecast, by Mode
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by Stage
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Functionality
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Deployment
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Solutions
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Mode
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.6 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.7 Asia-Pacific Market Size and Forecast, by Stage
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Functionality
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Deployment
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Solutions
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Mode
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Technology
      • 17.4.9.4 China Market Size and Forecast, by Application
      • 17.4.9.5 China Market Size and Forecast, by End User
      • 17.4.9.6 China Market Size and Forecast, by Stage
      • 17.4.9.7 China Market Size and Forecast, by Functionality
      • 17.4.9.8 China Market Size and Forecast, by Deployment
      • 17.4.9.9 China Market Size and Forecast, by Solutions
      • 17.4.9.10 China Market Size and Forecast, by Mode
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Technology
      • 17.4.10.4 India Market Size and Forecast, by Application
      • 17.4.10.5 India Market Size and Forecast, by End User
      • 17.4.10.6 India Market Size and Forecast, by Stage
      • 17.4.10.7 India Market Size and Forecast, by Functionality
      • 17.4.10.8 India Market Size and Forecast, by Deployment
      • 17.4.10.9 India Market Size and Forecast, by Solutions
      • 17.4.10.10 India Market Size and Forecast, by Mode
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Technology
      • 17.4.11.4 Japan Market Size and Forecast, by Application
      • 17.4.11.5 Japan Market Size and Forecast, by End User
      • 17.4.11.6 Japan Market Size and Forecast, by Stage
      • 17.4.11.7 Japan Market Size and Forecast, by Functionality
      • 17.4.11.8 Japan Market Size and Forecast, by Deployment
      • 17.4.11.9 Japan Market Size and Forecast, by Solutions
      • 17.4.11.10 Japan Market Size and Forecast, by Mode
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Technology
      • 17.4.12.4 South Korea Market Size and Forecast, by Application
      • 17.4.12.5 South Korea Market Size and Forecast, by End User
      • 17.4.12.6 South Korea Market Size and Forecast, by Stage
      • 17.4.12.7 South Korea Market Size and Forecast, by Functionality
      • 17.4.12.8 South Korea Market Size and Forecast, by Deployment
      • 17.4.12.9 South Korea Market Size and Forecast, by Solutions
      • 17.4.12.10 South Korea Market Size and Forecast, by Mode
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Technology
      • 17.4.13.4 Australia Market Size and Forecast, by Application
      • 17.4.13.5 Australia Market Size and Forecast, by End User
      • 17.4.13.6 Australia Market Size and Forecast, by Stage
      • 17.4.13.7 Australia Market Size and Forecast, by Functionality
      • 17.4.13.8 Australia Market Size and Forecast, by Deployment
      • 17.4.13.9 Australia Market Size and Forecast, by Solutions
      • 17.4.13.10 Australia Market Size and Forecast, by Mode
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Technology
      • 17.4.14.4 Singapore Market Size and Forecast, by Application
      • 17.4.14.5 Singapore Market Size and Forecast, by End User
      • 17.4.14.6 Singapore Market Size and Forecast, by Stage
      • 17.4.14.7 Singapore Market Size and Forecast, by Functionality
      • 17.4.14.8 Singapore Market Size and Forecast, by Deployment
      • 17.4.14.9 Singapore Market Size and Forecast, by Solutions
      • 17.4.14.10 Singapore Market Size and Forecast, by Mode
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.4 Indonesia Market Size and Forecast, by Application
      • 17.4.15.5 Indonesia Market Size and Forecast, by End User
      • 17.4.15.6 Indonesia Market Size and Forecast, by Stage
      • 17.4.15.7 Indonesia Market Size and Forecast, by Functionality
      • 17.4.15.8 Indonesia Market Size and Forecast, by Deployment
      • 17.4.15.9 Indonesia Market Size and Forecast, by Solutions
      • 17.4.15.10 Indonesia Market Size and Forecast, by Mode
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.4 Taiwan Market Size and Forecast, by Application
      • 17.4.16.5 Taiwan Market Size and Forecast, by End User
      • 17.4.16.6 Taiwan Market Size and Forecast, by Stage
      • 17.4.16.7 Taiwan Market Size and Forecast, by Functionality
      • 17.4.16.8 Taiwan Market Size and Forecast, by Deployment
      • 17.4.16.9 Taiwan Market Size and Forecast, by Solutions
      • 17.4.16.10 Taiwan Market Size and Forecast, by Mode
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.4 Malaysia Market Size and Forecast, by Application
      • 17.4.17.5 Malaysia Market Size and Forecast, by End User
      • 17.4.17.6 Malaysia Market Size and Forecast, by Stage
      • 17.4.17.7 Malaysia Market Size and Forecast, by Functionality
      • 17.4.17.8 Malaysia Market Size and Forecast, by Deployment
      • 17.4.17.9 Malaysia Market Size and Forecast, by Solutions
      • 17.4.17.10 Malaysia Market Size and Forecast, by Mode
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Functionality
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Solutions
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Technology
    • 17.5.5 Latin America Market Size and Forecast, by Application
    • 17.5.6 Latin America Market Size and Forecast, by End User
    • 17.5.7 Latin America Market Size and Forecast, by Stage
    • 17.5.8 Latin America Market Size and Forecast, by Functionality
    • 17.5.9 Latin America Market Size and Forecast, by Deployment
    • 17.5.10 Latin America Market Size and Forecast, by Solutions
    • 17.5.11 Latin America Market Size and Forecast, by Mode
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Technology
      • 17.5.9.4 Brazil Market Size and Forecast, by Application
      • 17.5.9.5 Brazil Market Size and Forecast, by End User
      • 17.5.9.6 Brazil Market Size and Forecast, by Stage
      • 17.5.9.7 Brazil Market Size and Forecast, by Functionality
      • 17.5.9.8 Brazil Market Size and Forecast, by Deployment
      • 17.5.9.9 Brazil Market Size and Forecast, by Solutions
      • 17.5.9.10 Brazil Market Size and Forecast, by Mode
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Technology
      • 17.5.10.4 Mexico Market Size and Forecast, by Application
      • 17.5.10.5 Mexico Market Size and Forecast, by End User
      • 17.5.10.6 Mexico Market Size and Forecast, by Stage
      • 17.5.10.7 Mexico Market Size and Forecast, by Functionality
      • 17.5.10.8 Mexico Market Size and Forecast, by Deployment
      • 17.5.10.9 Mexico Market Size and Forecast, by Solutions
      • 17.5.10.10 Mexico Market Size and Forecast, by Mode
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Technology
      • 17.5.11.4 Argentina Market Size and Forecast, by Application
      • 17.5.11.5 Argentina Market Size and Forecast, by End User
      • 17.5.11.6 Argentina Market Size and Forecast, by Stage
      • 17.5.11.7 Argentina Market Size and Forecast, by Functionality
      • 17.5.11.8 Argentina Market Size and Forecast, by Deployment
      • 17.5.11.9 Argentina Market Size and Forecast, by Solutions
      • 17.5.11.10 Argentina Market Size and Forecast, by Mode
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by Stage
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Functionality
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Deployment
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Solutions
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Mode
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.6 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.7 Middle East and Africa Market Size and Forecast, by Stage
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Functionality
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Deployment
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Solutions
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Mode
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by Stage
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Functionality
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Deployment
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Solutions
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Mode
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Technology
      • 17.6.10.4 UAE Market Size and Forecast, by Application
      • 17.6.10.5 UAE Market Size and Forecast, by End User
      • 17.6.10.6 UAE Market Size and Forecast, by Stage
      • 17.6.10.7 UAE Market Size and Forecast, by Functionality
      • 17.6.10.8 UAE Market Size and Forecast, by Deployment
      • 17.6.10.9 UAE Market Size and Forecast, by Solutions
      • 17.6.10.10 UAE Market Size and Forecast, by Mode
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Technology
      • 17.6.11.4 South Africa Market Size and Forecast, by Application
      • 17.6.11.5 South Africa Market Size and Forecast, by End User
      • 17.6.11.6 South Africa Market Size and Forecast, by Stage
      • 17.6.11.7 South Africa Market Size and Forecast, by Functionality
      • 17.6.11.8 South Africa Market Size and Forecast, by Deployment
      • 17.6.11.9 South Africa Market Size and Forecast, by Solutions
      • 17.6.11.10 South Africa Market Size and Forecast, by Mode
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by Stage
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Functionality
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Deployment
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Solutions
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Mode
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Adaptimmune Therapeutics
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Agenus
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Immunocore
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 MacroGenics
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 OncoSec Medical
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Surface Oncology
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Celyad Oncology
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Kura Oncology
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Iovance Biotherapeutics
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 TCR2 Therapeutics
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Calithera Biosciences
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Harpoon Therapeutics
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Gritstone bio
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 NextCure
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 ImmunoGen
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis